BioSante Pharmaceuticals, Inc. announced today's presentation of H1N1 vaccine results at the Immunotherapeutics Vaccine Summit in Providence, RI. BioSante's vaccine adjuvant, BioVant, increased the protective effect of vaccines for multiple flu strains, including a potential new vaccine against H1N1 (swine flu), which resulted in 100 percent protection from symptoms of illness, including weight loss, and death in animal studies.